Daren Tang (600329.SH) Branch obtained a drug registration certificate for loxoprofen sodium patch

Zhitongcaijing · 2d ago

Zhitong Finance App News, Da Ren Tang (600329.SH) issued an announcement. Xinxin Pharmaceutical Factory of Jinyao Da Rentang Group Co., Ltd., which belongs to the company, recently received the “Drug Registration Certificate” for loxoprofen sodium patches approved and issued by the State Drug Administration. Using a novel hot melt patch technology, loxoprofen sodium patch is an upgraded product of loxoprofen sodium gel patch. It has the characteristics of being lightweight, comfortable to apply, and has strong adhesiveness. It is used for anti-inflammatory and analgesic pain in the following diseases and symptoms: osteoarthritis, muscle pain, and swelling or pain caused by trauma.

The drug is declared according to the 4 categories of chemicals. After approval, it is treated as if it has passed the consistency evaluation. This approval for listing is another key achievement of the company's strategic layout in the field of transdermal administration. It indicates that the company has full-process “R&D, production and quality control” capabilities for modern patches represented by gel paste and hot-melt patches. In the future, it will rely on the clinical accumulation of traditional Chinese medicine in the musculoskeletal system field and continue to build a modern patch product matrix covering “chemical-traditional medicine-health patches”.